Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells

  • Authors:
    • Wen Ouyang
    • Chunxu Yang
    • Simin Zhang
    • Yu Liu
    • Bo Yang
    • Junhong Zhang
    • Fuxiang Zhou
    • Yunfeng Zhou
    • Conghua Xie
  • View Affiliations

  • Published online on: December 20, 2012     https://doi.org/10.3892/ijo.2012.1748
  • Pages: 699-711
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a major limitation for its clinical use. The mechanisms of TRAIL resistance have been mostly studied in the context of cell lines that are intrinsically resistant to TRAIL. However, little is known about the molecular alterations that contribute to the development of acquired resistance during treatment with TRAIL. In this study, we established H460R, an isogenic cell line with acquired TRAIL resistance, from the TRAIL‑sensitive human lung cancer cell line H460 to investigate the mechanisms of acquired resistance. The acquired TRAIL‑resistant H460R cells remained sensitive to cisplatin. The mRNA and protein expression levels of death receptor 4 (DR4) and death receptor 5 (DR5) were not altered in either of the TRAIL-treated cell lines. Nevertheless, tests in which the DR4 or DR5 gene was overexpressed or silenced suggest that death receptor expression is necessary but not sufficient for TRAIL‑induced apoptosis. Compared with parental TRAIL-sensitive H460 cells, H460R cells showed a decreased TRAIL-induced translocation of DR4/DR5 into lipid rafts. Further studies showed that nystatin partially prevented lipid raft aggregation and DR4 and DR5 clustering and reduced apoptosis in H460 cells again. Analysis of apoptotic molecules showed that more pro-caspase-8, FADD, caspase-3 and Bid, but less cFLIP in H460 cells than in H460R cells. Our findings suggest that the lack of death receptor redistribution negatively impacts DISC assembly in lipid rafts, which at least partially leads to the development of acquired resistance to TRAIL in H460R cells.
View Figures
View References

Related Articles

Journal Cover

February 2013
Volume 42 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ouyang, W., Yang, C., Zhang, S., Liu, Y., Yang, B., Zhang, J. ... Xie, C. (2013). Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. International Journal of Oncology, 42, 699-711. https://doi.org/10.3892/ijo.2012.1748
MLA
Ouyang, W., Yang, C., Zhang, S., Liu, Y., Yang, B., Zhang, J., Zhou, F., Zhou, Y., Xie, C."Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells". International Journal of Oncology 42.2 (2013): 699-711.
Chicago
Ouyang, W., Yang, C., Zhang, S., Liu, Y., Yang, B., Zhang, J., Zhou, F., Zhou, Y., Xie, C."Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells". International Journal of Oncology 42, no. 2 (2013): 699-711. https://doi.org/10.3892/ijo.2012.1748